These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 6670281

  • 1. Epidermal Langerhans cells in mycosis fungoides and Sézary syndrome.
    Matejka M, Konrad K.
    Wien Klin Wochenschr; 1983 Dec 09; 95(23):847-52. PubMed ID: 6670281
    [Abstract] [Full Text] [Related]

  • 2. Lymphocyte-epidermis interactions in malignant epidermotropic lymphomas: I. Ultrastructural aspects.
    Schmitt D, Thivolet J.
    Acta Derm Venereol; 1980 Dec 09; 60(1):1-11. PubMed ID: 6153827
    [Abstract] [Full Text] [Related]

  • 3. Epidermal Langerhans cells and prognosis of patients with mycosis fungoides and Sezary syndrome.
    Meissner K, Löning T, Rehpenning W.
    In Vivo; 1993 Dec 09; 7(3):277-80. PubMed ID: 8357970
    [Abstract] [Full Text] [Related]

  • 4. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA, Mitchell T, Ferreira S, Seed PT, Russell-Jones R, Calonje E, Whittaker SJ.
    Br J Dermatol; 2006 Oct 09; 155(4):756-62. PubMed ID: 16965425
    [Abstract] [Full Text] [Related]

  • 5. Mycosis fungoides/Sézary syndrome: report of an unusual case.
    Mehta A, Dhungel BM, Khan MF.
    J Cutan Pathol; 2006 Sep 09; 33 Suppl 2():12-5. PubMed ID: 16972946
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
    Kim YH, Liu HL, Mraz-Gernhard S, Varghese A, Hoppe RT.
    Arch Dermatol; 2003 Jul 09; 139(7):857-66. PubMed ID: 12873880
    [Abstract] [Full Text] [Related]

  • 11. Langerhans cells and their precursors with S100 protein in mycosis fungoides.
    Igisu K, Watanabe S, Shimosato Y, Kukita A.
    Jpn J Clin Oncol; 1983 Dec 09; 13(4):693-702. PubMed ID: 6196502
    [Abstract] [Full Text] [Related]

  • 12. [Mycosis fungoides and Sézary syndrome: diagnostic and prognostic relevance of cellular antigen expression].
    Meissner K, Löning T, Rehpenning W.
    Hautarzt; 1991 Feb 09; 42(2):84-91. PubMed ID: 2037492
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemical studies using monoclonal antibodies on lymph nodes from patients with mycosis fungoides and Sézary's syndrome.
    Willemze R, Scheffer E, Meijer CJ.
    Am J Pathol; 1985 Jul 09; 120(1):46-54. PubMed ID: 3893151
    [Abstract] [Full Text] [Related]

  • 14. Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
    Jarrousse V, Quereux G, Marques-Briand S, Knol AC, Khammari A, Dreno B.
    Eur J Dermatol; 2006 Jul 09; 16(6):636-41. PubMed ID: 17229603
    [Abstract] [Full Text] [Related]

  • 15. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH, Tensen CP, van der Stoop PM, van Oostveen HW, Lund M, Scheper RJ, Willemze R.
    Arch Dermatol; 2001 Jul 09; 137(7):901-5. PubMed ID: 11453809
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.